You are here

Regeneron

What Fovista's Fail Means For OHR Pharma

Yahoo/Benzinga

Wed, 12/14/16 - 09:17 am

Ohr Pharmaceutical

wet age-related macular degeneration

Pharma execs assess landscape under President Trump

Drug Delivery Business

Sat, 12/3/16 - 09:22 am

pharma industry

Regeneron, Sanofi Drug Delayed by Plant Snag

Investopedia

Thu, 12/1/16 - 04:33 pm

drug manufacturing

No early success for Regeneron, Sanofi in PhIII outcomes study for PCSK9 drug Praluent

Endpoints

Thu, 11/17/16 - 09:54 am

PCSK9 inhibitors

Regeneron tops 3Q profit forecasts

Yahoo/AP

Fri, 11/4/16 - 09:30 am

These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating

Stat

Fri, 10/28/16 - 10:07 am

PCSK9 inhibitors

FDA places Regeneron and Teva's pain-drug study on hold

Yahoo/Reuters

Mon, 10/17/16 - 11:56 am

Teva Pharmaceutical

lower back pain

clinical trials

Regeneron picks a new delivery tech in effort to upgrade flagship blockbuster Eylea

Endpoints

Thu, 10/13/16 - 10:41 am

Ocular Therapeutix

Is Another Blockbuster Drug on the Way for Regeneron Pharmaceuticals, Inc.?

Motley Fool

Mon, 10/10/16 - 09:03 am

atopic dermatitis

Hard To See If Regeneron's Eylea Combo Study Failure Reads Through To Ophthotech's Fovista

Yahoo/Benzinga

Tue, 10/4/16 - 10:17 am

clinical trials

Regeneron's Eylea combination therapy fails mid-stage study

Yahoo/Reuters

Fri, 09/30/16 - 09:45 am

clinical trials

wet age-related macular degeneration

3 Critical FDA Decisions You Can't Afford to Miss

Motley Fool

Tue, 09/27/16 - 10:13 pm

Vertex Pharmaceuticals

FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme

Bizjournals.com

Mon, 09/26/16 - 09:45 am

rheumatoid arthritis

Teva, Regeneron enter deal potentially worth up to $2.6 billion to develop pain therapy fasinumab

First Word Pharma

Tue, 09/20/16 - 11:11 am

Teva Pharmaceutical

Amgen, Sanofi and Regeneron trot out new PCSK9 data at European heart meeting

Fierce Pharma

Mon, 08/29/16 - 05:52 pm

PCSK9 inhibitors

These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year

Motley Fool

Sun, 08/28/16 - 10:07 am

PCSK9 inhibitors

Are PCSK9 meds worth the cost? Only if Amgen, Sanofi and Regeneron slash prices by two-thirds: JAMA

Fierce Pharma

Wed, 08/17/16 - 12:11 pm

PCSK9 inhibitors

Amgen, Sanofi Cholesterol Drugs Not Cost-Effective, Study Says

Bloomberg

Tue, 08/16/16 - 04:34 pm

Eylea sales lift Regeneron's profit past estimates

Yahoo/Reuters

Thu, 08/4/16 - 10:01 am

Regeneron leaps into the blockbuster race to develop off-the-shelf immune cell cancer therapies

Endpoints

Tue, 08/2/16 - 09:00 am

drug development

cancer immunotherapy

Pages